Accelsiors CRO
Pavel Tumanov has extensive work experience in the clinical research industry. Pavel started their career at Sagmel Inc., USA, where they worked as a Brand Manager from May 2002 to November 2004. In 2003, they joined Accelsiors CRO as the Local Head of Clinical Operations and SCRA. Pavel held this role for 13 years until June 2016. At Accelsiors CRO, they also served as the Senior Regional Clinical Operations Manager and Director from June 2016 to September 2017. From September 2017, they took on the position of Executive Director of Clinical Operations for the USA, Europe, and MENA countries. As of January 2021, Pavel Tumanov is the Vice President of the Late Stage Development unit at Accelsiors CRO.
Pavel Tumanov attended Bogomolets National Medical University from 1991 to 1997, where they obtained a degree in Pediatrics.
This person is not in any offices
Accelsiors CRO
1 followers
Accelsiors is a scientifically-driven, global, full-service Contract Research Organization (CRO). We support the Pharma industry globally to accelerate and manage every activity across clinical drug development. Since 2002, we have been committed to providing Sponsors working in highly complex disease indications with the scientific knowledge, regulatory expertise and quality operations necessary to achieve their development objectives. Accelsiors expertise includes studies in the following areas: • Biosimilars • Complex Generics • Endocrinology • Hepatology • Infectious Disease • Inflammatory Disease • Nephrology • Neurology • Oncology • Pulmonary • Rare Diseases • Rheumatology We serve a global Customer base, which ranges from emerging biotechnology companies to multi-national pharmaceutical companies. Accelsiors is committed to establishing meaningful collaborations with our Sponsors and executing studies, regardless of size and scope, with quality being the key driver in all that we do.